ADcure

The upside potential of taurx will be measured in the billions, not millions. The risk/reward for Dundee, warrants hanging on to taurx. If they want to sell, I would be a buyer for a few shares, even tho I don't have millions.

Lady I know was diagnosed w/ early on-set AD in 2011 (age 62) and was in Tau Rx trials since then and has actually improved mentally overall. Granted, that is just 1 case, but----

One needs to read FULLY the results of TauRx trials before recommending fire sale of that asset.

Would that investor be Genting or someone else? Thanks

2 things about Taurx's drug, #1 it was given "orphan drug status" by FDA for some dementia. #2 if one reads the complete results of last phase 3 trial it becomes apparent that the drug does have a lot of merit, even surprising the folks at Taurx, thus the new trial Lucidty.

I believe that sale of Taurx prior to IPO would be a monumental mistake.

To safety in numbers, Anyone else involved? Yes

Just read rcfunds report. Am I missing something? If Dundee has a market cap of $70 million, and marketable securities of $162 million, why doesn't someone buy Dundee and sell/liquidate it, double their money, and put it out of its misery?

With cash on hand of about 40M and annual needs of about 59M, how long do you think till they hit zero, seriously? Thanks for your thoughts